BRIEF-Portage Biotech Announces Letter Of Intent With Immunova For An Option To Acquire Iox Therapeutics

+3.54%

+0.78%

+1.00%

+1.51%

Portage Biotech Inc Ordinary Shares PRTG	4.10	+3.54%
Dow Jones Industrial Average DJI	43487.83	+0.78%
S&P 500 INDEX SPX	5996.66	+1.00%
NASDAQ IXIC	19630.20	+1.51%

Dec 17 (Reuters) - Portage Biotech Inc PRTG.O:

PORTAGE BIOTECH ANNOUNCES LETTER OF INTENT WITH IMMUNOVA FOR AN OPTION TO ACQUIRE IOX THERAPEUTICS, LTD
PORTAGE BIOTECH INC - HAVE AGREED WITH IMMUNOVA TO NEGOTIATE ACQUISITION OF IOX THERAPEUTICS

Source text: ID:nGNX28Y9jt

Further company coverage: PRTG.O

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.